These results suggest that it is not that ATRX mutation lacks prognostic significance but that conventional detection methods, such as NGS and IHC, may mistakenly classify some gliomas with ATRX mutation but with a low proportion of mutant tumor cells as ATRX wild‐type. This evidence concerns the gene ATRX and neoplasm.